According to IMARC Group latest report titled” Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market is currently witnessing strong growth. The global parenteral nutrition market size to grow at a CAGR of around 7% during 2021-2026. Parenteral nutrition (PN) refers to the intravenous (IV) administration of liquid nutrition, such as fats, carbohydrates, proteins, vitamins, minerals, and electrolytes. It helps in preventing malnutrition and maintaining energy and hydration. As a result, it is used among individuals of all ages who are unable to eat or absorb enough food through tube feeding formula or by mouth.
Get a sample copy of this Report: https://www.imarcgroup.com/parenteral-nutrition-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
There is a significant rise in the number of people with diseases, such as short bowel syndrome, gastrointestinal (GI) fistulas, bowel obstruction, and severe acute pancreatitis, which impair food intake and nutrient digestion. This, in confluence with the increasing access to healthcare services, represents one of the major factors catalyzing the demand for PN worldwide. Apart from this, health agencies of numerous countries, along with non-governmental organizations (NGOs), are focusing on reducing the early birth mortality rates. This, coupled with the growing cases of childhood malnutrition, especially in emerging countries, is anticipated to influence the need for PN positively.
View Full Report with TOC & List of Figure: https://bit.ly/3zS11QG
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Aculife Healthcare Private Limited
- Braun Melsungen AG
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Otsuka Pharmaceutical Factory Inc.
- Pfizer Inc.
- Servona GmbH
Parenteral Nutrition Market Segmentation:
Our report has categorized the market based on region, nutrient type and end use.
Breakup by Nutrient Type:
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Breakup by End User:
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800